• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立并验证了一种可用于盐酸噻氯匹定片剂制剂中盐酸噻氯匹定含量测定的稳定性指示型 UPLC 方法。

Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation.

机构信息

Department of Chemistry, Saurashtra University, Rajkot 360 005, Gujarat, India.

出版信息

Saudi Pharm J. 2011 Jul;19(3):159-64. doi: 10.1016/j.jsps.2011.03.005. Epub 2011 Mar 21.

DOI:10.1016/j.jsps.2011.03.005
PMID:23960754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3745131/
Abstract

The objective of the current study was the development of a simple, precise and accurate isocratic reversed-phase stability indicating Ultra Performance Liquid Chromatography [UPLC] assay method and validated for determination of ticlopidine hydrochloride in solid pharmaceutical dosage forms. Isocratic separation was achieved on a Zorbax SB-C18 (50 mm × 4.6 mm, 1.8 μm) column using mobile phase of methanol-0.01 M ammonium acetate buffer, pH 5.0 (80:20, v/v) at a flow rate of 0.8 ml min(-1), the injection volume was 4.0 μl and the detection was carried out at 235 nm by using photo-diode array detector. The drug was subjected to oxidation, hydrolysis, photolysis and heat to apply stress condition. The method was validated for specificity, linearity, precision, accuracy, robustness and solution stability. The method was linear in the drug concentration range of 62.5-375 μg ml(-1) with a correlation coefficient of 0.9999. The precision (relative standard deviation - RSD) of six samples was 1.31% for repeatability and the intermediate precision [RSD] among six-sample preparation was 0.77%. The accuracy (recovery) was between 98.80% and 101.50%. Degradation products produced as a result of stress studies did not interfere with detection of ticlopidine hydrochloride and the assay can thus be considered stability indicating.

摘要

本研究的目的是开发一种简单、精确和准确的等度反相稳定性指示超高效液相色谱[UPLC]分析方法,并对其进行验证,以测定固体制剂中盐酸噻氯匹定的含量。等度分离在 Zorbax SB-C18(50mm×4.6mm,1.8μm)柱上实现,流动相为甲醇-0.01M 乙酸铵缓冲液,pH5.0(80:20,v/v),流速为 0.8ml/min,进样体积为 4.0μl,检测波长为 235nm,采用光电二极管阵列检测器。药物经氧化、水解、光解和热解处理,以施加应条件。该方法经过专属性、线性、精密度、准确度、耐用性和溶液稳定性验证。该方法在药物浓度范围为 62.5-375μg/ml 时具有线性,相关系数为 0.9999。六个样品的精密度(相对标准偏差-RSD)为 1.31%,重复性良好,六个样品制备的中间精密度[RSD]为 0.77%。准确度(回收率)在 98.80%和 101.50%之间。在应激研究中产生的降解产物不会干扰盐酸噻氯匹定的检测,因此可以认为该测定方法具有稳定性指示作用。

相似文献

1
Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation.建立并验证了一种可用于盐酸噻氯匹定片剂制剂中盐酸噻氯匹定含量测定的稳定性指示型 UPLC 方法。
Saudi Pharm J. 2011 Jul;19(3):159-64. doi: 10.1016/j.jsps.2011.03.005. Epub 2011 Mar 21.
2
Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.一种用于同时测定片剂制剂中螺内酯和呋塞米的稳定性指示高效液相色谱分析方法的开发与验证
J Chromatogr Sci. 2012 Sep;50(8):721-6. doi: 10.1093/chromsci/bms062. Epub 2012 May 28.
3
Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation.用于测定片剂制剂中奈必洛尔的稳定性指示柱高效液相色谱测定法的开发与验证。
J AOAC Int. 2008 May-Jun;91(3):557-61.
4
New Stability-Indicating RP-UFLC Method for Determination of Trospium Chloride in Tablet Dosage Form.用于测定片剂剂型中氯化托烷司琼的新型稳定性指示反相超高效液相色谱法
Sci Pharm. 2012 Oct-Dec;80(4):955-64. doi: 10.3797/scipharm.1207-07. Epub 2012 Aug 31.
5
Method Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Dronedarone Hydrochloride in Pharmaceutical Tablets.用于定量分析药品片剂中盐酸决奈达隆的稳定性指示反相高效液相色谱法的方法开发与验证
Sci Pharm. 2013 Jan-Mar;81(1):115-22. doi: 10.3797/scipharm.1209-15. Epub 2012 Nov 5.
6
New Stability-Indicating RP-HPLC Method for Determination of Diclofenac Potassium and Metaxalone from their Combined Dosage Form.用于测定双氯芬酸钾和美他沙酮复方制剂中双氯芬酸钾和美他沙酮的新型稳定性指示反相高效液相色谱法
Sci Pharm. 2012 Jan-Mar;80(1):127-37. doi: 10.3797/scipharm.1109-16. Epub 2011 Dec 5.
7
A Stability-indicating HPLC Method for Assay of Lercanidipine Hydrochloride in Tablets and for Determining Content Uniformity.一种用于测定片剂中盐酸乐卡地平含量及含量均匀度的稳定性指示高效液相色谱法。
Indian J Pharm Sci. 2010 May;72(3):381-4. doi: 10.4103/0250-474X.70490.
8
Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.高效液相色谱法测定原料药和片剂中依普罗沙坦的方法开发与验证
J AOAC Int. 2010 Nov-Dec;93(6):1862-7.
9
UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.超高效液相色谱法(UPLC)和液相色谱 - 质谱联用(LC - MS)对盐酸伊立替康降解行为的研究以及开发一种经验证的稳定性指示超高效液相色谱法,用于测定药物剂型中盐酸伊立替康及其杂质。
J Chromatogr Sci. 2012 Oct;50(9):810-9. doi: 10.1093/chromsci/bms075. Epub 2012 Jun 1.
10
Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets.用于测定药片中盐酸非索非那定及其相关杂质的经验证的稳定性指示色谱方法的开发。
Chem Cent J. 2011 Dec 3;5(1):76. doi: 10.1186/1752-153X-5-76.

引用本文的文献

1
Development and Validation of a Stability-Indicating Capillary Electrophoresis Method for the Determination of Zolpidem Tartrate in Tablet Dosage Form with Positive Confirmation using 2D- and 3D-DAD Fingerprints.采用二维和三维二极管阵列检测器指纹图谱进行阳性确证的稳定性指示毛细管电泳法测定片剂剂型中酒石酸唑吡坦的方法开发与验证
Sci Pharm. 2014 Feb 27;82(2):341-56. doi: 10.3797/scipharm.1401-11. Print 2014 Apr-Jun.

本文引用的文献

1
Acute and long-term antiplatelet therapy.急性和长期抗血小板治疗。
Drugs Today (Barc). 2008 May;44(5):331-52. doi: 10.1358/dot.2008.44.5.1215717.
2
Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions.西洛他唑可降低股腘动脉病变患者血管内治疗后的再狭窄发生率。
J Vasc Surg. 2008 Jul;48(1):144-9. doi: 10.1016/j.jvs.2008.02.062. Epub 2008 May 14.
3
Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.抗血小板治疗策略:评估其在急性冠状动脉综合征中的当前作用。
Clin Cardiol. 2008 Mar;31(3 Suppl 1):I2-9. doi: 10.1002/clc.20362.
4
Quantitative nondestructive methods for the determination of ticlopidine in tablets using reflectance near-infrared and Fourier transform Raman spectroscopy.使用反射近红外光谱和傅里叶变换拉曼光谱法测定片剂中噻氯匹定的定量无损方法。
Appl Spectrosc. 2008 Feb;62(2):251-7. doi: 10.1366/000370208783575636.
5
Ticlopidine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study.采用高效液相色谱-电喷雾串联质谱法对人血浆中的噻氯匹定进行定量分析及其在生物等效性研究中的应用
J Mass Spectrom. 2004 Dec;39(12):1562-9. doi: 10.1002/jms.708.
6
ICH guidance in practice: establishment of inherent stability of secnidazole and development of a validated stability-indicating high-performance liquid chromatographic assay method.
J Pharm Biomed Anal. 2004 Nov 19;36(4):769-75. doi: 10.1016/j.jpba.2004.08.008.
7
Development of validated stability-indicating assay methods--critical review.经过验证的稳定性指示分析方法的开发——批判性综述
J Pharm Biomed Anal. 2002 Jun 15;28(6):1011-40. doi: 10.1016/s0731-7085(02)00047-x.
8
The ICH guidance in practice: stress degradation studies on ornidazole and development of a validated stability-indicating assay.ICH指南在实际应用中:奥硝唑的强制降解研究及一种经过验证的稳定性指示分析方法的开发
J Pharm Biomed Anal. 2001 Dec;26(5-6):891-7. doi: 10.1016/s0731-7085(01)00475-7.
9
A stability study of ticlopidine products from 18 countries.
Drug Dev Ind Pharm. 2000 Apr;26(4):391-401. doi: 10.1081/ddc-100101245.
10
Liquid chromatographic method for the determination of ticlopidine in human plasma.测定人血浆中噻氯匹定的液相色谱法。
J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):393-8. doi: 10.1016/s0378-4347(97)00082-0.